Peptides - GH Secretagogues
Tesamorelin
FDA-approved GHRH analog that targets visceral fat
Dosage
1-2mg daily
Results
8-12 weeks
Frequency
Daily
Cost
$300-500/month
Estimated monthly
$300-500
About Tesamorelin
Tesamorelin is an FDA-approved GHRH analog originally developed to reduce visceral adipose tissue in HIV patients with lipodystrophy. It has since gained attention for its ability to target stubborn abdominal fat while improving cognitive function. Clinical studies have demonstrated significant reductions in visceral fat with continued use.
Administration
Method
Subcutaneous injection
Timing
PM
Food
Take fasted
Key Benefits
- Reduces visceral abdominal fat
- Improves body composition
- FDA-approved with clinical data
- Enhances cognitive function
- Supports metabolic health
Stacks Well With
Important Considerations
- • Diabetes
- • Active cancer
- • Pregnancy
- • Pituitary disorders
Additional Notes
- • FDA-approved for lipodystrophy
- • Premium option for visceral fat
Research & Studies
Tesamorelin: Visceral Fat Reduction in HIV Patients
2010·Clinical Trial
Tesamorelin: Cognitive Effects in Healthy Adults
2016·Clinical Trial
Research provided for educational purposes. Always consult a healthcare provider.